Original language | English |
---|---|
Journal | Journal of Clinical Oncology |
Volume | 35 |
DOIs | |
Publication status | Published - 20 May 2017 |
Association of concomitant use of acid reducing agents in full-dose vemurafenib users with risk of progression in BRAF V600 mutation-positive unresectable or metastatic melanoma patients: A retrospective cohort study.
Lotte Marieke Knapen, Rutger H. T. Koornstra, Johanna H. M. Driessen, Bas Van Vlijmen, Sander Croes, Stein J. Schalkwijk, Angela Colbers, Winald Gerritsen, David Burger, Frank de Vries, Nielka P. Van Erp
Research output: Contribution to journal › Meeting Abstract › Academic